BACKGROUND Ruminant mycoplasmoses are important diseases worldwide and several are listed by the World Organization for Animal Health to be of major economic significance. In France the distribution of mycoplasmal species isolated from clinical samples collected from diseased animals upon veterinary request, is monitored by a network known as VIGIMYC (for VIGIlance to MYCoplasmoses of ruminants...

Mycoplasma hyopneumoniae is the primary agent of enzootic pneumonia in pigs. The lung lesions, generally observed in young pigs, are characterised by a hyperplasia of the epithelial cells and an increased perivascular and peribronchiolar accumulation of mononuclear cells. Following M. hyopneumoniae infection, immune reactions are observed and resistance is induced in pigs. Laboratory diagnosis ...

Development of animal models to explore possible relationships between mycoplasmas and chronic progressive respiratory disease of man could take two general courses. One approach could be study of naturally-occurring chronic respiratory diseases associated with mycoplasmas in animals and birds in order to gain insight into the nature of the host-parasite relationship that could be applied subse...

Vaccination is an option for controlling Mycoplasma gallisepticum or M. synoviae when biosecurity measures fail to prevent the infection of poultry flocks with these mycoplasmas. Both killed vaccines (bacterins) and living vaccines are currently in commercial use. Bacterins usually contain an oil emulsion adjuvant and are administered by subcutaneous or intramuscular injection. They can reduce ...

Mycoplasma bovis is a cell-wall-less bacterium and belongs to the class Mollicutes. It is the most important etiological agent of bovine mycoplasmoses in North America and Europe, causing respiratory disease, mastitis, otitis media, arthritis, and reproductive disease. Clinical disease associated with M. bovis is often chronic, debilitating, and poorly responsive to antimicrobial therapy, resul...